JP2022069377A - 血管性浮腫の処置 - Google Patents
血管性浮腫の処置 Download PDFInfo
- Publication number
- JP2022069377A JP2022069377A JP2021074664A JP2021074664A JP2022069377A JP 2022069377 A JP2022069377 A JP 2022069377A JP 2021074664 A JP2021074664 A JP 2021074664A JP 2021074664 A JP2021074664 A JP 2021074664A JP 2022069377 A JP2022069377 A JP 2022069377A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063104919P | 2020-10-23 | 2020-10-23 | |
| US63/104,919 | 2020-10-23 | ||
| US202163147595P | 2021-02-09 | 2021-02-09 | |
| US63/147,595 | 2021-02-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022069377A true JP2022069377A (ja) | 2022-05-11 |
| JP2022069377A5 JP2022069377A5 (https=) | 2024-04-23 |
Family
ID=81521900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021074664A Pending JP2022069377A (ja) | 2020-10-23 | 2021-04-27 | 血管性浮腫の処置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2022069377A (https=) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019106361A1 (en) * | 2017-11-29 | 2019-06-06 | Kalvista Pharmaceuticals Limited | Dosage forms comprising a plasma kallikrein inhibitor |
-
2021
- 2021-04-27 JP JP2021074664A patent/JP2022069377A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019106361A1 (en) * | 2017-11-29 | 2019-06-06 | Kalvista Pharmaceuticals Limited | Dosage forms comprising a plasma kallikrein inhibitor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102748728B1 (ko) | 유전성 혈관부종의 치료 방법 | |
| JP7640474B2 (ja) | 血管性浮腫の治療 | |
| US20230381162A1 (en) | Treatments of angioedema | |
| US20240122909A1 (en) | Treatments of hereditary angioedema | |
| US20250281397A1 (en) | Formulations of a plasma kallikrein inhibitor | |
| JP2022069377A (ja) | 血管性浮腫の処置 | |
| HK40101443A (en) | Treatments of hereditary angioedema | |
| HK40070596B (en) | Treatments of hereditary angioedema | |
| HK40070596A (en) | Treatments of hereditary angioedema | |
| EA048676B1 (ru) | Лечение наследственного ангионевротического отека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20210526 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240415 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240415 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250319 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250430 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251028 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260128 |